Optomed Oyj

HEL-OPTOMED
Nasdaq Helsinki NYSE
Healthcare Health Information Services
Global Rank
#24941
Country Rank
n/a
Market Cap
91.94 M
Price
4.79
Change (%)
2.33%
Volume
67,591

Optomed Oyj's latest marketcap:

91.94 M

As of 06/05/2025, Optomed Oyj's market capitalization has reached $91.94 M. According to our data, Optomed Oyj is the 24941th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 91.94 M
Revenue (ttm) 18.01 M
Net Income (ttm) -6,801,791.49
Shares Out 19.66 M
EPS (ttm) -0.35
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/07/2025
Market Cap Chart
Data Updated: 06/05/2025

Optomed Oyj's yearly market capitalization.

Optomed Oyj has seen its market value drop from €95.5 M to €80.31 M since 2020, representing a total decrease of 15.91% and an annual compound decline rate (CAGR) of 3.83%.
Date Market Cap Change (%)
06/05/2025 €80.31 M -12.23%
12/30/2024 €91.61 M 38.72%
12/29/2023 €66.04 M 9.08%
12/30/2022 €60.54 M -54.37%
12/30/2021 €132.68 M 38.93%
12/30/2020 €95.5 M

Company Profile

About Optomed Oyj

Optomed Oyj, along with its subsidiaries, specializes in the manufacturing and sale of handheld fundus cameras, serving customers in Finland, Europe, and internationally.

Business Segments

  • Devices: Develops, manufactures, and sells fundus cameras for healthcare professionals, including ophthalmologists, pediatricians, and neurologists.
  • Software: Provides IT consulting services and innovative software solutions for government institutions and healthcare providers.

Product Offerings

Camera Brands:

  • Optomed Smartscope Pro
  • Optomed Aurora
  • Optomed Aurora AEYE
  • Optomed Polaris
  • OEM cameras under Volk Optical, Carl Zeiss Meditec, and Topcon

Software Solutions:

  • Avenue AI – AI-powered tool for eye specialists
  • Avenue Eye Screen – Workflow management for disease screening
  • Avenue Flow – Eyecare management software
  • Avenue Telemedicine – Remote analysis solution
  • Cancer Screen – Screening process management
  • Optomed RIS – Healthcare imaging software
  • Sectra PACS – Modular system for healthcare providers
  • Optomed Service Portal – Support for healthcare units
  • Cephalometry – Orthodontic and maxillofacial surgery software
  • Pathology PACS – Digital pathology image review and sharing

Distribution & Sales

The company distributes its products through OEM partnerships, distributors, and direct sales to hospitals, eye clinics, and optician chains.

Company Background

Founded in 2004, Optomed Oyj is headquartered in Oulu, Finland.

Frequently Asked Questions

  • What is Optomed Oyj's (HEL-OPTOMED) current market cap?
    As of 06/05/2025, Optomed Oyj (including the parent company, if applicable) has an estimated market capitalization of $91.94 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Optomed Oyj global market capitalization ranking is approximately 24941 as of 06/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.